Hematologic Malignancy
Lymphoid Neoplasm
CI-CAN-00009335Explore in graph →
Hematologic2,419 active trials60 approved drugs271 evidence items
- OncoTree
- LNM
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00009335Explore in graph →
Clinical trials
8,885 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,373)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03513601 | Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma | unknown | Phase 4 | 20 | Mingzhi ZhangOTHER | 1 | May 1, 2018 | clinicaltrials |
| NCT00211211 | FREE Study - Fracture Reduction Evaluation | completed | Phase 4 | 300 | Medtronic Spine LLCINDUSTRY | 1 | Dec 8, 2017 | clinicaltrials |
| NCT01746992 |
| unknown |
| Phase 4 |
| 200 |
| Ruijin HospitalOTHER |
| 1 |
| Nov 14, 2017 |
| clinicaltrials |
| NCT00430352 | MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma. | completed | Phase 4 | 545 | Hoffmann-La RocheINDUSTRY | 24 | Aug 14, 2017 | clinicaltrials |
| NCT01569724 | Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma(TgBEX) | completed | Phase 4 | 10 | Rennes University HospitalOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT03150602 | A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy | unknown | Phase 4 | 22 | Taiwan Mundipharma Pharmaceuticals Ltd.INDUSTRY | 1 | May 12, 2017 | clinicaltrials |
| NCT01625455 | Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome | terminated | Phase 4 | 7 | Vanderbilt University Medical CenterOTHER | 1 | May 10, 2017 | clinicaltrials |
| NCT00361140 | Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) | completed | Phase 4 | 72 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT01410929 | Evaluation of Vertebral Compression Fracture Fixation With RF Kyphoplasty in Patients With Multiple Myeloma(MM) | withdrawn | Phase 4 | 0 | DFINE Inc.INDUSTRY | 0 | Jan 20, 2017 | clinicaltrials |
| NCT02487316 | A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib | withdrawn | Phase 4 | 0 | Jun ZhuOTHER | 1 | Dec 30, 2016 | clinicaltrials |
| NCT02585947 | To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma | unknown | Phase 4 | 90 | Seoul National University HospitalOTHER | 1 | Dec 21, 2016 | clinicaltrials |
| NCT02996617 | PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia | unknown | Phase 4 | 240 | Shandong Provincial HospitalOTHER_GOV | 1 | Dec 19, 2016 | clinicaltrials |
| NCT02782845 | An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) | completed | Phase 4 | 53 | Hoffmann-La RocheINDUSTRY | 2 | Nov 21, 2016 | clinicaltrials |
| NCT02938741 | ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors | unknown | Phase 4 | 130 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 25, 2016 | clinicaltrials |
| NCT01664975 | Treatment of Peripheral T-cell Lymphoma | completed | Phase 4 | 100 | Mingzhi ZhangOTHER | 1 | Oct 5, 2016 | clinicaltrials |
| NCT02268890 | A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma | completed | Phase 4 | 18 | Johnson & Johnson Taiwan LtdINDUSTRY | 1 | Jul 11, 2016 | clinicaltrials |
| NCT01949818 | Treatment of Diffuse Large B Cell Lymphoma | unknown | Phase 4 | 120 | Mingzhi ZhangOTHER | 1 | Dec 30, 2015 | clinicaltrials |
| NCT01960192 | Treatment of Primary CNS Lymphoma(FVD) | unknown | Phase 4 | 50 | Mingzhi ZhangOTHER | 1 | Jul 21, 2015 | clinicaltrials |
| NCT01501136 | Treatment of Natural Killer/T Cell Lymphoma-I/II(CTTNKTL-I/II) | unknown | Phase 4 | 200 | Mingzhi ZhangOTHER | 1 | Jul 17, 2015 | clinicaltrials |
| NCT01501149 | Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ(CTTNKTL-Ⅲ/Ⅳ) | unknown | Phase 4 | 80 | Mingzhi ZhangOTHER | 1 | Jul 17, 2015 | clinicaltrials |
| NCT00242528 | Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma. | withdrawn | Phase 4 | 0 | NovartisINDUSTRY | 0 | Apr 14, 2015 | clinicaltrials |
| NCT00352703 | PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation | completed | Phase 4 | 145 | Swedish Orphan BiovitrumINDUSTRY | 0 | Nov 3, 2014 | clinicaltrials |
| NCT00808171 | Evaluation of the Analgesy With Emla and/or Nitrous Oxide in Pediatric Patients for Lumbar Puncture | completed | Phase 4 | 52 | Federal University of Minas GeraisOTHER | 1 | Jul 29, 2014 | clinicaltrials |
| NCT01164475 | Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms | completed | Phase 4 | 61 | Genzyme, a Sanofi CompanyINDUSTRY | 4 | Feb 25, 2014 | clinicaltrials |
| NCT01990807 | Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia | unknown | Phase 4 | 20 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 21, 2013 | clinicaltrials |
| NCT00969462 | Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma | completed | Phase 4 | 18 | Meir Medical CenterOTHER | 1 | Jul 1, 2013 | clinicaltrials |
| NCT01868828 | A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma | unknown | Phase 4 | 50 | Peking University People's HospitalOTHER | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00926757 | Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B(HBVNHL) | completed | Phase 4 | 80 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | May 29, 2013 | clinicaltrials |
| NCT00114348 | ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia | completed | Phase 4 | 338 | Charite University, Berlin, GermanyOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00162955 | Prevention of CHOP-induced Chronic Cardiotoxicity | completed | Phase 4 | 150 | Osaka City UniversityOTHER | 1 | May 8, 2012 | clinicaltrials |
| NCT00029224 | Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions | completed | Phase 4 | 500 | NovartisINDUSTRY | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00652041 | Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma(TaCyDexVMP7) | completed | Phase 4 | 40 | PETHEMA FoundationOTHER | 1 | Sep 19, 2011 | clinicaltrials |
| NCT01418430 | Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) | completed | Phase 4 | — | King's College Hospital NHS TrustOTHER | 1 | Aug 22, 2011 | clinicaltrials |
| NCT00104104 | A Multiple Myeloma Trial in Patients With Bone Metastases | completed | Phase 4 | 179 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 29, 2011 | clinicaltrials |
| NCT01249690 | Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma | unknown | Phase 4 | 100 | Second Military Medical UniversityOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00199017 | German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults | completed | Phase 4 | 75 | Johann Wolfgang Goethe University HospitalOTHER | 1 | Aug 23, 2010 | clinicaltrials |
| NCT01124526 | Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma | completed | Phase 4 | 75 | Asociacion Espanola de Hematologia y HemoterapiaOTHER | 1 | May 17, 2010 | clinicaltrials |
| NCT00466258 | LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)(LINFOTARGAM) | completed | Phase 4 | 50 | PETHEMA FoundationOTHER | 1 | Nov 25, 2009 | clinicaltrials |
| NCT00090038 | Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma | completed | Phase 4 | 168 | BiogenINDUSTRY | 11 | Oct 20, 2009 | clinicaltrials |
| NCT00797810 | Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults | unknown | Phase 4 | 25 | University of BolognaOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00630903 | PUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides(MF99) | terminated | Phase 4 | 54 | Madrilenian Group of Cutaneous LymphomasOTHER | 1 | Mar 7, 2008 | clinicaltrials |
| NCT00050999 | Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients | completed | Phase 4 | 195 | Eisai Inc.INDUSTRY | 10 | Mar 5, 2008 | clinicaltrials |
| NCT00051012 | Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients | completed | Phase 4 | 86 | Eisai Inc.INDUSTRY | 9 | Mar 5, 2008 | clinicaltrials |
| NCT00257114 | Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and Tolerability | completed | Phase 4 | — | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00188149 | Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET | unknown | Phase 4 | 300 | University Hospital Carl Gustav CarusOTHER | 1 | Dec 29, 2005 | clinicaltrials |
Data updated 22 days agoSource updated May 1, 2018source: clinicaltrials